NYSE:USPH - U.S. Physical Therapy Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$116.50 -1.75 (-1.48 %)
(As of 09/20/2018 03:55 PM ET)
Previous Close$118.40
Today's Range$115.95 - $118.40
52-Week Range$57.80 - $129.65
Volume1,371 shs
Average Volume51,165 shs
Market Capitalization$1.54 billion
P/E Ratio56.85
Dividend Yield0.76%
U.S. Physical Therapy logoU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Health services
Sub-IndustryHealth Care Facilities


Debt-to-Equity Ratio0.27
Current Ratio2.06
Quick Ratio2.06


Trailing P/E Ratio56.85
Forward P/E Ratio46.41
P/E Growth4.32

Sales & Book Value

Annual Sales$414.05 million
Price / Sales3.57
Cash Flow$2.7335 per share
Price / Cash42.62
Book Value$16.38 per share
Price / Book7.11


EPS (Most Recent Fiscal Year)$2.08
Net Income$22.25 million
Net Margins5.03%
Return on Equity13.81%
Return on Assets6.77%


Outstanding Shares12,690,000
Market Cap$1.54 billion

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Friday, August 3rd. Stockholders of record on Tuesday, August 14th will be paid a dividend of $0.23 per share on Friday, September 7th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date of this dividend is Monday, August 13th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its quarterly earnings data on Thursday, August, 2nd. The company reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.68 by $0.05. The company earned $115.10 million during the quarter, compared to analyst estimates of $111.77 million. U.S. Physical Therapy had a return on equity of 13.81% and a net margin of 5.03%. The business's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the company posted $0.59 EPS. View U.S. Physical Therapy's Earnings History.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for U.S. Physical Therapy.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share (EPS) guidance of $2.45-2.55 for the period, compared to the Thomson Reuters consensus estimate of $2.44.

What price target have analysts set for USPH?

4 brokerages have issued 1 year price targets for U.S. Physical Therapy's shares. Their forecasts range from $90.00 to $105.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $97.50 in the next twelve months. This suggests that the stock has a possible downside of 16.3%. View Analyst Price Targets for U.S. Physical Therapy.

What is the consensus analysts' recommendation for U.S. Physical Therapy?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for U.S. Physical Therapy.

What are Wall Street analysts saying about U.S. Physical Therapy stock?

Here are some recent quotes from research analysts about U.S. Physical Therapy stock:
  • 1. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. " (8/7/2018)
  • 2. Barrington Research analysts commented, "We are maintaining our MARKET PERFORM investment rating on USPH shares due to valuation concerns. This is genuinely frustrating because we continue to really like this business and its management team. That said, to hold a constructive investment rating on USPH shares, we would need to assign more than a 23.5x EV/EBITDA multiple to our 2019 estimate. As much as we like the company, such a valuation seems a bit much." (8/3/2018)
  • 3. Cantor Fitzgerald analysts commented, "1Q18 results were in-line with our expectations, driven by a 7.4% jump in patient visits, new practices and a full quarter’s contribution from its workforce performance solutions business." (5/3/2018)

Who are some of U.S. Physical Therapy's key competitors?

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 54)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 63)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 61)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 54)
  • Mr. Jon C. Bates, VP & Corp. Controller

Has U.S. Physical Therapy been receiving favorable news coverage?

Press coverage about USPH stock has been trending somewhat positive on Thursday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. U.S. Physical Therapy earned a news and rumor sentiment score of 0.18 on Accern's scale. They also gave media stories about the company an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future. View Recent Headlines for U.S. Physical Therapy.

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.80%), Renaissance Technologies LLC (5.15%), Riverbridge Partners LLC (3.90%), Standard Life Aberdeen plc (3.74%), BTIM Corp. (1.76%) and Northern Trust Corp (1.72%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Jerald L Pullins, Lawrance W Mcafee and Mark J Brookner. View Institutional Ownership Trends for U.S. Physical Therapy.

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Fred Alger Management Inc., Royce & Associates LP, Standard Life Aberdeen plc, Janus Henderson Group PLC, Cadence Capital Management LLC, FMR LLC, King Luther Capital Management Corp and Rice Hall James & Associates LLC. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Jerald L Pullins, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was acquired by a variety of institutional investors in the last quarter, including BTIM Corp., Riverbridge Partners LLC, BlackRock Inc., First Trust Advisors LP, Renaissance Technologies LLC, Citadel Advisors LLC, Brown Advisory Inc. and Northern Trust Corp. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $116.50.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.54 billion and generates $414.05 million in revenue each year. The company earns $22.25 million in net income (profit) each year or $2.08 on an earnings per share basis. U.S. Physical Therapy employs 4,300 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]

MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  426
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel